interactions:
- request:
    body: retmax=1000&db=pubmed&retmode=xml&api_key=<omitted>&id=23878845&id=16080930
    headers:
      Accept:
      - application/json
      Accept-Encoding:
      - gzip, deflate
      Connection:
      - keep-alive
      Content-Length:
      - '102'
      Content-Type:
      - application/x-www-form-urlencoded
      User-Agent:
      - hawc
    method: POST
    uri: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi
  response:
    body:
      string: '<?xml version="1.0" ?>

        <!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January
        2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">

        <PubmedArticleSet>

        <PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23878845</PMID><DateCompleted><Year>2015</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>27</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Electronic">1936-7163</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>44</Volume><Issue>10</Issue><PubDate><Year>2013</Year><Season>Nov-Dec</Season></PubDate></JournalIssue><Title>Quintessence
        international (Berlin, Germany : 1985)</Title><ISOAbbreviation>Quintessence
        Int</ISOAbbreviation></Journal><ArticleTitle>Randomized clinical evaluation
        of the effect of chlorhexidine on postoperative sensitivity of posterior composite
        resin restorations.</ArticleTitle><Pagination><StartPage>793</StartPage><EndPage>798</EndPage><MedlinePgn>793-8</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.3290/j.qi.a30176</ELocationID><Abstract><AbstractText
        Label="OBJECTIVES" NlmCategory="OBJECTIVE">Evaluation of postoperative sensitivity
        in posterior teeth restored with etchand- rinse adhesive and composite resin
        after application of 2% chlorhexidine solution.</AbstractText><AbstractText
        Label="METHOD AND MATERIALS" NlmCategory="METHODS">Thirty participants with
        similar dental caries on both sides of the jaws were selected. After cavity
        preparation, each tooth was randomized to one of the following restoration
        methods. Teeth in the control group were restored using etch-and-rinse resin
        adhesive (Single Bond, 3M ESPE) and universal microhybrid composite resin
        (Filtek Z250, 3M ESPE). Restoration of teeth in the experimental group was
        similar to the control group except that 2% chlorhexidine solution (Concepsis,
        Ultradent) was applied on the etched dentin for 60 seconds. Subjects were
        recalled for evaluation of postoperative sensitivity at 1 day, 1 week, 1 month,
        and 6 months. Data were analyzed by Fisher exact test (&#x3b1; = .05).</AbstractText><AbstractText
        Label="RESULTS" NlmCategory="RESULTS">The experimental group showed significantly
        less postoperative sensitivity (8 teeth) compared with the control group (20
        teeth) at the 1-day recall (P &lt; .05; Fisher exact test). Conventional restorations
        were comparable to teeth treated with chlorhexidine at other recall times
        (P &gt; .05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Chlorhexidine
        significantly decreased immediate postoperative sensitivity of posterior teeth
        restored by composite resin.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Hajizadeh</LastName><ForeName>Hila</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Ghavamnasiri</LastName><ForeName>Marjaneh</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Majidinia</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized
        Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support,
        Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Quintessence
        Int</MedlineTA><NlmUniqueID>0342677</NlmUniqueID><ISSNLinking>0033-6572</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012117">Resins, Synthetic</NameOfSubstance></Chemical><Chemical><RegistryNumber>R4KO0DY52L</RegistryNumber><NameOfSubstance
        UI="D002710">Chlorhexidine</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName
        UI="D002710" MajorTopicYN="N">Chlorhexidine</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003793" MajorTopicYN="N">Dental Restoration, Permanent</DescriptorName><QualifierName
        UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003807" MajorTopicYN="N">Dentin Sensitivity</DescriptorName><QualifierName
        UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName
        UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012117" MajorTopicYN="Y">Resins, Synthetic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">23878845</ArticleId><ArticleId IdType="doi">10.3290/j.qi.a30176</ArticleId><ArticleId
        IdType="pii">840687</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">16080930</PMID><DateCompleted><Year>2006</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-5037</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>40</Volume><Issue>8</Issue><PubDate><Year>2005</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal
        of pediatric surgery</Title><ISOAbbreviation>J Pediatr Surg</ISOAbbreviation></Journal><ArticleTitle>Effects
        of prenatal vitamins A, E, and C on the hypoplastic hearts of fetal rats with
        diaphragmatic hernia.</ArticleTitle><Pagination><StartPage>1269</StartPage><EndPage>1274</EndPage><MedlinePgn>1269-74</MedlinePgn></Pagination><Abstract><AbstractText
        Label="BACKGROUND/AIM" NlmCategory="OBJECTIVE">Nitrofen induces heart hypoplasia
        together with congenital diaphragmatic hernia (CDH) in rats. Intracellular
        oxidative stress might be one of the mechanisms of action of the teratogen,
        and vitamin A has been shown to reverse in part these effects when administered
        simultaneously or shortly after it. This study aims at testing the hypothesis
        that vitamin A and other antioxidant vitamins, such as E and C, could improve
        myocardial development even when administered late in gestation, a likely
        useful period for prenatal medication.</AbstractText><AbstractText Label="MATERIAL
        AND METHODS" NlmCategory="METHODS">Time-mated Sprague-Dawley female rats were
        exposed to either vehicle (control) or 100 mg of nitrofen (experimental) on
        day 9.5 of gestation. In 3 additional groups, the animals were exposed to
        vitamin A (total 15000 IU), vitamin E (total 150 IU), or vitamin C (total
        150 IU) on days 16, 17, and 18. The fetuses were recovered on day 21, and
        randomly selected hearts of those with CDH were processed for histologic studies
        (hematoxylin-eosin and periodic acid-Schiff stainings), DNA and protein contents,
        and ki-67 (proliferation) and terminal deoxynucleotidyl transferase-mediated
        dUTP-biotin end labeling (apoptosis) studies. The differences among groups
        were assessed by analysis of variance with Bonferroni/Dunn post hoc tests
        and a threshold of significance of P &lt; .05.</AbstractText><AbstractText
        Label="RESULTS" NlmCategory="RESULTS">Nitrofen induced heart hypoplasia in
        terms of decreased heart/body weight, cell mass (less DNA and protein), and
        proportion of proliferating cells with increased apoptosis. Vitamin C alleviated
        weight hypoplasia and the 3 vitamins were able to restore cell mass and to
        reestablish near-normal figures of proliferation and apoptosis.</AbstractText><AbstractText
        Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Antioxidant vitamins A, E, and
        C given late in gestation alleviate heart hypoplasia that accompanies CDH
        in the rat model. This timing suggests that the beneficial effects are exerted
        on the maturational phase of development.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Reyes</LastName><ForeName>Salom&#xe9;</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department
        of Pediatric Surgery, Research Laboratory, Hospital Universitario La Paz,
        28046 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez</LastName><ForeName>Leopoldo</ForeName><Initials>L</Initials></Author><Author
        ValidYN="Y"><LastName>Tovar</LastName><ForeName>Juan A</ForeName><Initials>JA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>J Pediatr Surg</MedlineTA><NlmUniqueID>0052631</NlmUniqueID><ISSNLinking>0022-3468</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D016877">Oxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010647">Phenyl Ethers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D013723">Teratogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014815">Vitamins</NameOfSubstance></Chemical><Chemical><RegistryNumber>11103-57-4</RegistryNumber><NameOfSubstance
        UI="D014801">Vitamin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>1406-18-4</RegistryNumber><NameOfSubstance
        UI="D014810">Vitamin E</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>N71UYG034A</RegistryNumber><NameOfSubstance
        UI="C007350">nitrofen</NameOfSubstance></Chemical><Chemical><RegistryNumber>PQ6CK8PD0R</RegistryNumber><NameOfSubstance
        UI="D001205">Ascorbic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001205" MajorTopicYN="N">Ascorbic Acid</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627"
        MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005318" MajorTopicYN="N">Fetal Heart</DescriptorName><QualifierName UI="Q000002"
        MajorTopicYN="N">abnormalities</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006330" MajorTopicYN="N">Heart Defects, Congenital</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006548" MajorTopicYN="N">Hernia, Diaphragmatic</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D065630" MajorTopicYN="Y">Hernias, Diaphragmatic, Congenital</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020287" MajorTopicYN="N">In Situ Nick-End Labeling</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016877" MajorTopicYN="N">Oxidants</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic
        use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010647"
        MajorTopicYN="N">Phenyl Ethers</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011297" MajorTopicYN="N">Prenatal Exposure Delayed Effects</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013723" MajorTopicYN="N">Teratogens</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014801" MajorTopicYN="N">Vitamin A</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic
        use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014810"
        MajorTopicYN="N">Vitamin E</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName
        UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014815" MajorTopicYN="N">Vitamins</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic
        use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2005</Year><Month>8</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2006</Year><Month>3</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2005</Year><Month>8</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">16080930</ArticleId><ArticleId IdType="doi">10.1016/j.jpedsurg.2005.05.009</ArticleId><ArticleId
        IdType="pii">S0022-3468(05)00369-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>'
    headers:
      Access-Control-Allow-Origin:
      - '*'
      Access-Control-Expose-Headers:
      - X-RateLimit-Limit,X-RateLimit-Remaining
      Cache-Control:
      - private
      Connection:
      - Keep-Alive
      Content-Security-Policy:
      - upgrade-insecure-requests
      Content-Type:
      - text/xml; charset=UTF-8
      Date:
      - Thu, 05 Sep 2024 23:00:58 GMT
      Keep-Alive:
      - timeout=4, max=40
      NCBI-PHID:
      - D0BD9D8EE5AB4CE5000028EF79373C39.1.1.m_3
      NCBI-SID:
      - 55DD4F32A4149AFB_9EC1SID
      Referrer-Policy:
      - origin-when-cross-origin
      Server:
      - Finatra
      Set-Cookie:
      - ncbi_sid=55DD4F32A4149AFB_9EC1SID; domain=.nih.gov; path=/; expires=Fri, 05
        Sep 2025 23:00:59 GMT
      Strict-Transport-Security:
      - max-age=31536000; includeSubDomains; preload
      Transfer-Encoding:
      - chunked
      X-RateLimit-Limit:
      - '10'
      X-RateLimit-Remaining:
      - '6'
      X-UA-Compatible:
      - IE=Edge
      X-XSS-Protection:
      - 1; mode=block
      content-encoding:
      - gzip
    status:
      code: 200
      message: OK
version: 1
